BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-03+107,469→ 107,469 totalExercise: $13.00Exp: 2035-01-02→ Common Stock (107,469 underlying) - Award
Restricted Stock Units
2025-01-03+72,004→ 72,004 total→ Common Stock (72,004 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
- [F2]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.